XORTX Therapeutics Inc (XRTX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.319x

Based on the latest financial reports, XORTX Therapeutics Inc (XRTX) has a cash flow conversion efficiency ratio of -0.319x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-629.62K ≈ $-455.46K USD) by net assets (CA$1.97 Million ≈ $1.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see XORTX Therapeutics Inc stock valuation for the company's overall valuation and market capitalisation.

XORTX Therapeutics Inc - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how XORTX Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

XORTX Therapeutics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of XORTX Therapeutics Inc ranked by their cash flow conversion efficiency. Explore XORTX Therapeutics Inc cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Click Holdings Limited NASDAQ:CLIK	-0.002x
Maxeon Solar Technologies Ltd NASDAQ:MAXN	0.148x
Chinhung International Inc. Pfd. Series 2 KO:002787	-0.027x
AltynGold plc LSE:ALTN	0.155x
BELLUSCURA PLC LS -01 F:9VQ	N/A
Akg Exim Limited NSE:AKG	0.050x
Enterprise Metals Ltd AU:ENT	-0.065x
Secure Trust Bank PLC LSE:STB	-0.575x

Annual Cash Flow Conversion Efficiency for XORTX Therapeutics Inc (2018–2024)

The table below shows the annual cash flow conversion efficiency of XORTX Therapeutics Inc from 2018 to 2024. View XORTX Therapeutics Inc stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$3.34 Million ≈ $2.41 Million	CA$-3.68 Million ≈ $-2.66 Million	-1.103x	+22.26%
2023-12-31	CA$4.64 Million ≈ $3.36 Million	CA$-6.58 Million ≈ $-4.76 Million	-1.418x	+17.35%
2022-12-31	CA$6.97 Million ≈ $5.05 Million	CA$-11.97 Million ≈ $-8.66 Million	-1.716x	-373.73%
2021-12-31	CA$16.74 Million ≈ $12.11 Million	CA$-6.06 Million ≈ $-4.39 Million	-0.362x	+37.53%
2020-12-31	CA$1.26 Million ≈ $908.75K	CA$-728.40K ≈ $-526.91K	-0.580x	-149.19%
2019-12-31	CA$-211.72K ≈ $-153.16K	CA$-249.58K ≈ $-180.54K	1.179x	+124.37%
2018-12-31	CA$321.54K ≈ $232.60K	CA$-1.56 Million ≈ $-1.13 Million	-4.837x	--

About XORTX Therapeutics Inc

V:XRTX Canada Biotechnology

Market Cap

$16.07 Million

CA$22.21 Million CAD

Market Cap Rank

#29289 Global

#1363 in Canada

Share Price

CA$3.19

Change (1 day)

+4.59%

52-Week Range

CA$0.49 - CA$3.96

All Time High

CA$387.99